首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2013年 2期 => 病毒性肝炎 =>拉米夫定联合血浆置换治疗乙型肝炎..
拉米夫定联合血浆置换治疗乙型肝炎相关慢加急性肝衰竭的疗效分析
Evaluation of the therapeutic efficacy of lamivudine combined with plasma exchange for treating acute-on-chronic hepatitis B liver failure
文章发布日期:2013年02月01日  来源:  作者:胡启江,江应安  点击次数:2447次  下载次数:538次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的观察拉米夫定联合血浆置换治疗乙型肝炎相关慢加急性肝衰竭的临床疗效。方法选择乙型肝炎相关慢加急性肝衰竭患者92例,随机分为2组,治疗组47例,对照组45例。2组采用类似的内科基础治疗,均给予拉米夫定100 mg/d,治疗组加血浆置换,采用终末期肝病评分模型(MELD),比较2组患者在MELD<30、30≤MELD<40和MELD≥40 3个亚组中的存活率的差异。结果治疗组总存活率为63.82%,而对照组总存活率为4444% (χ2=4.31,P<0.05);在30≤MELD<40亚组中治疗组存活率为71.42%,而对照组存活率为38.10% (χ2=4. 71,P<005), 在MELD<30和MELD≥40亚组中,治疗组存活率与对照组分别相比,差异无统计学意义(P>0.05)。结论30≤MELD<40的乙型肝炎相关慢加急性肝衰竭患者采用拉米夫定联合血浆置换治疗能提高患者存活率。
【Abstract】:ObjectiveTo observe the clinical effects of lamivudine antiviral therapy combined with plasma exchange in patients with acute-on-chronic hepatitis B liver failure. MethodsForty-seven patients (treatment group) were administered lamivudine and underwent plasma exchange. An additional forty-five patients (control group) were administered lamivudine but no plasma exchange. Otherwise, all patients received the same basic medical treatment. The two groups were further divided into three sub-groups according to the model for end-stage liver disease (MELD) score: <30, 30-39, and ≥40. The significance of differences in survival rates between the groups and sub-groups was determined by the χ2 test. ResultsThe overall survival rate was significantly better in the treatment group (63.82% vs. control group: 44.44%; χ2=4.31, P<0.05). Within the treatment group, the survival rates were highest in the 30-39 MELD score sub-group (71.42%), which was significantly different from survival rate in the same sub-group of the controls (vs. 38.10%; χ2=4.71, P<005). The other two MELD score sub-groups showed no significant differences between the treatment and control groups (all P>0.05). ConclusionCombined therapy consisting of lamivudine treatment and plasma exchange can improve the survival rate of patients with acute-on-chronic hepatitis B liver failure who have MELD scores between 30 and 39.
【关键字】:肝功能衰竭;血浆置换;拉米夫定;肝炎,乙型
【Key words】:liver failure; plasma exchange; lamivudine; hepatitis B
【引证本文】:

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号